GLP-1 receptor agonists like semaglutide show promise in reducing obesity-related cancer risks, while highlighting the need for ongoing safety monitoring.
Alyssa Modic, PharmD, explains how pharmacists can clarify pneumococcal vaccine schedules, manage co-administration decisions, and reframe vaccination conversations for patients.